Patent intelligence · US
US 11744834
Metal-porphyrin complexes for the inactivation of the biological activity of opioids
Metal-porphyrin complexes for the inactivation of the biological activity of opioids
Patent details — US 11744834
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 5, 2023
- Expiration
- Aug 31, 2043
- Applicant
- The Government of the United States of America, as represented by the Secretary of the Navy
- Claims
- 2
- CPC classes
- A61K, A61K31/555, A61K47/546, A61K47/6923
Quick answer
US 11744834 (Metal-porphyrin complexes for the inactivation of the biological activity of opioids) is held by The Government of the United States of America, as represented by the Secretary of the Navy. Status: granted. Granted Sep 5, 2023. Expires Aug 31, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- The Government of the United States of America, as represented by the Secretary of the Navy
- Grant date
- Expiration
- Claims
- 2
- CPC classes
- A61K, A61K31/555, A61K47/546, A61K47/6923, A61K47/6929, A61P
More from The Government of the United States of America, as represented by the Secretary of the Navy
Related pharmaceutical patents in our USPTO index.
-
US 12419873
Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases
granted -
US 12419941
Poultry drinking water-based vaccine delivery system and method
granted -
US 12415845
Methods of producing T cell populations using hydroxycitric acid and/or a salt thereof
granted -
US 12410240
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection
granted -
US 12410259
CD47 targeted therapies for the treatment of infectious disease
granted -
US 12404317
T cell receptors recognizing MHC class II-restricted MAGE-A3
granted -
US 12397066
Delivery of gene therapy treatments
granted -
US 12398123
Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria
granted
Frequently asked questions
What is US patent 11744834?
US 11744834 (Metal-porphyrin complexes for the inactivation of the biological activity of opioids) is held by The Government of the United States of America, as represented by the Secretary of the Navy. Status: granted. Granted Sep 5, 2023. Expires Aug 31, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11744834?
The Government of the United States of America, as represented by the Secretary of the Navy is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3,720 pharmaceutical patents for this assignee.
When does US 11744834 expire?
Our index shows an expiration date of Aug 31, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.